Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists Workshop


Por: Arrigo, M, Price, S, Baran, DA, Poss, J, Aissaoui, N, Bayes-Genis, A, Bonello, L, Francois, B, Gayat, E, Gilard, M, Kapur, NK, Karakas, M, Kostrubiec, M, Leprince, P, Levy, B, Rosenberg, Y, Thiele, H, Zeymer, U, Harhay, MO and Mebazaa, A

Publicada: 1 oct 2021 Ahead of Print: 1 sep 2021
Resumen:
Acute myocardial infarction complicated by cardiogenic shock (AMICS) is a critical syndrome with a high risk of morbidity and mortality. Current management consists of coronary revascularisation, vasoactive drugs, and circulatory and ventilatory support, which are tailored to patients mainly on the basis of clinicians' experience rather than evidence-based recommendations. For many therapeutic interventions in AMICS, randomised clinical trials have not shown a meaningful survival benefit, and a disproportionately high rate of neutral and negative results has been reported. In this context, an accurate definition of the AMICS syndrome for appropriate patient selection and optimisation of study design are warranted to achieve meaningful results and pave the way for new, evidence-based therapeutic options. In this Position Paper, we provide a statement of priorities and recommendations agreed by a multidisciplinary group of experts at the Critical Care Clinical Trialists Workshop in February, 2020, for the optimisation and harmonisation of clinical trials in AMICS. Implementation of proposed criteria to define the AMICS population-moving beyond a cardio-centric definition to that of a systemic disease-and steps to improve the design of clinical trials could lead to improved outcomes for patients with this life-threatening syndrome.

Filiaciones:
Arrigo, M:
 Triemli Hosp Zurich, Dept Internal Med, Zurich, Switzerland

 Univ Zurich, Zurich, Switzerland

Price, S:
 Royal Brompton Hosp, London, England

 Imperial Coll London, Natl Heart & Lung Inst, London, England

Baran, DA:
 Sentara Heart Hosp, Eastern Virginia Med Sch, Adv Heart Failure Ctr, Norfolk, VA USA

Poss, J:
 Univ Leipzig, Dept Cardiol, Heart Ctr Leipzig, Leipzig, Germany

Aissaoui, N:
 Penn State Univ, Inst Heart & Vasc, Crit Care Unit, Hershey Med Ctr, Harrisburg, PA USA

 Hop Europeen Georges Pompidou, AP HP, Dept Crit Care, Paris, France

:
 Germans Trias & Pujol Badalona, Inst Heart, Madrid, Spain

 Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid, Spain

Bonello, L:
 Aix Marseille Univ, Aix En Provence, France

 Hop Nord Marseille, AP HM, Dept Cardiol, Intens Care Unit,Mediterranean Assoc Res & Studie, Marseille, France

Francois, B:
 Dupuytren Univ Hosp, Dept Intens Care, Limoges, France

 Dupuytren Univ Hosp, INSERM CIC1435 & UMR1092, Limoges, France

Gayat, E:
 Hop Univ St Louis Lariboisiere, AP HP, Dept Anesthesia Burn & Crit Care Med, FHU PROMICE INICRCT, Paris, France

 Univ Paris, MASCOT, INSERM, Paris, France

Gilard, M:
 Brest Univ Hosp, Dept Cardiol, Brest, France

Kapur, NK:
 Cardiovasc Ctr Res & Innovat, Acute Circulatory Support Program, Intervent Res Labs, Boston, MA USA

Karakas, M:
 Univ Med Ctr, Dept Intens Care Med, Hamburg, Germany

 Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany

 German Ctr Cardiovasc Res DZHK, Hamburg, Germany

Kostrubiec, M:
 Univ Warsaw, Dept Internal Med & Cardiol, Warsaw, Poland

 Mid & South Essex NHS Fdn Trust, Broomfield, England

Leprince, P:
 Pitie Salpetrere Hosp, AP HP, Dept Cardiovasc Surg, Paris, France

 Sorbonne Univ, Paris, France

Levy, B:
 Univ Lorraine, Med Intens & Reanimat Brabois, CHRU Nancy, Nancy, France

 Univ Lorraine, INSERM U1116, Nancy, France

Rosenberg, Y:
 Natl Heart Lung & Blood Inst, Bethesda, MD USA

Thiele, H:
 Univ Leipzig, Dept Cardiol, Heart Ctr Leipzig, Leipzig, Germany

Zeymer, U:
 Klinikum Ludwigshafen, Ludwigshafen, Germany

 Inst Herzinfarktforschung, Ludwigshafen, Germany

Harhay, MO:
 Univ Penn, Palliat & Adv Illness Res PAIR, Ctr Clin Trials Methods & Outcomes Lab, Philadelphia, PA USA

 Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA USA

Mebazaa, A:
 Hop Univ St Louis Lariboisiere, AP HP, Dept Anesthesia Burn & Crit Care Med, FHU PROMICE INICRCT, Paris, France

 Univ Paris, MASCOT, INSERM, Paris, France
ISSN: 22132600





LANCET RESPIRATORY MEDICINE
Editorial
The Lancet Publishing Group, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 9 Número: 10
Páginas: 1192-1202
WOS Id: 000748982900028
ID de PubMed: 34245691

MÉTRICAS